Your browser doesn't support javascript.
loading
The cancer proteomic landscape and the HUPO Cancer Proteome Project.
Jimenez, Connie R; Zhang, Hui; Kinsinger, Christopher R; Nice, Edouard C.
Afiliação
  • Jimenez CR; 1OncoProteomics Laboratory, Department of Medical Oncology, Cancer Center Amsterdam, VU University Medical Center, Amsterdam, The Netherlands.
  • Zhang H; 2Department of Pathology, Mass Spectrometry Core Facility, Center for Biomarker Discovery and Translation, Johns Hopkins University, Baltimore, MD 21287 USA.
  • Kinsinger CR; 3Office of the Clinical Proteomic, Tumor Analysis Consortium at the National Cancer Institute, National Institutes of Health, Bethesda, MD 20892 USA.
  • Nice EC; 4Department of Biochemistry and Molecular Biology, Monash University, Clayton, VIC 3800 Australia.
Clin Proteomics ; 15: 4, 2018.
Article em En | MEDLINE | ID: mdl-29416445
ABSTRACT
The Human Cancer Proteome Project (Cancer-HPP) is an international initiative organized by HUPO whose key objective is to decipher the human cancer proteome through a coordinated effort by cancer proteome researchers around the world. The ultimate goal is to map the entire human cancer proteome to disclose tumor biology and drive improved diagnostics, treatment and management of cancer. Here we report the progress in the cancer proteomics field to date, and discuss future proteomic developments that will be needed to optimally delineate cancer phenotypes and advance the molecular characterization of this significant disease that is one of the leading causes of death worldwide.
Palavras-chave

Texto completo: 1 Base de dados: MEDLINE Idioma: En Ano de publicação: 2018 Tipo de documento: Article

Texto completo: 1 Base de dados: MEDLINE Idioma: En Ano de publicação: 2018 Tipo de documento: Article